Arca
Skip to content
Tools
Tools

Potassium

Metal that 5 drugs act on.

  • Drugs that act on it: 5
  • Approved: 4
  • In phases 1 to 3: 1
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 5

Approved4

  • Sodium zirconium cyclosilicate
  • Patiromer calcium
  • Sodium polystyrene sulfonate
  • Patiromer sorbitex calcium

Phase 31

  • Patiromer

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 5 act as: Potassium chelating agent; the rest name their own mechanism.
      Sodium zirconium cyclosilicateApprovedAstraZeneca PharmaceuticalsSmall moleculeChelating agent8
      Patiromer calciumApprovedCSLSmall moleculeChelating agent5
      Sodium polystyrene sulfonateApprovedConcordia PharmaceuticalsSmall moleculeSequestering agentPotassium sequestering agent2
      Patiromer sorbitex calciumApprovedCSLSmall moleculeChelating agent0
      PatiromerPhase 3CSLSmall moleculeChelating agent5

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 14 in all, from ClinicalTrials.gov.
      A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With HyperkalaemiaSodium zirconium cyclosilicatePhase 4RecruitingAstraZenecaNov 18, 2026
      OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sodium zirconium cyclosilicatePhase 2Not yet recruitingSahlgrenska University HospitalMay 8, 2026
      Swedish Cardiac And Renal Failure Study-1Sodium zirconium cyclosilicatePhase 2RecruitingKarolinska InstitutetJun 19, 2025
      Patiromer and Diet/hrQoL in Chronic DialysisPatiromer, Patiromer calciumPhase 3RecruitingMario Negri Institute for Pharmacological ResearchMar 5, 2025
      the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis PatientsSodium zirconium cyclosilicatePhase 4Not yet recruitingQianfoshan HospitalDec 16, 2024
      Keeping RAASi Treatment With Optimal Potassium ControlSodium zirconium cyclosilicatePhase 3RecruitingFundación para la Investigación del Hospital Clínico de ValenciaAug 29, 2024
      A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly PatientsSodium zirconium cyclosilicatePhase 3RecruitingFundación para la Investigación del Hospital Clínico de ValenciaAug 29, 2024
      Potassium Correction for RAAS Optimization in Chronic Kidney DiseasePatiromer, Patiromer calciumPhase 4RecruitingUniversity Medical Center GroningenFeb 13, 2024
      Incremental Hemodialysis: The TwoPlus TrialPatiromer, Patiromer calciumNot applicableRecruitingWake Forest University Health SciencesApr 25, 2023
      Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium LevelsPatiromer, Patiromer calciumPhase 2RecruitingVifor Pharma, Inc.Mar 13, 2023
      Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney DiseasePatiromer, Patiromer calciumNot applicableActive, not recruitingNand WadhwaSep 20, 2021
      OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart FailureSodium polystyrene sulfonate, Sodium zirconium cyclosilicatePhase 2Active, not recruitingMichael FuMar 9, 2021
      An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaSodium zirconium cyclosilicatePhase 3RecruitingAstraZenecaJan 23, 2019
      Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)Sodium polystyrene sulfonateNot applicableActive, not recruitingSociete ACTIVBIOMATApr 14, 2017

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3545434, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.